Glutathione 주사에 의해 유발된 치명적인 천식발작 1예
A case of glutathione-induced life-threatening asthma attack
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Baek-ok injection (glutathione) has been widely used antioxidant therapy to whiten and has antiaging effects in Korea. Glutathione is an enzyme which synthesizes leukotriene, then it can induce asthma attack theoretically; however, there have been few case reports concerning this therapy. In this report, we described a 41-year-old woman who developed glutathione-induced life-threatening asthma attack. She has asthma history controlled by an intermittent salbutamol inhaler. She developed general weakness and dyspnea right after glutathione injection, and injection was discontinued. Dyspnea was progressively aggravated, and she lost consciousness with shock. Cardiopulmonary resuscitation was started, and she arrived at the Emergency Department with wheezing, hypoxia, severe respiratory acidosis, and nonmeasurable blood pressure. Intubation and mechanical ventilation were started with intramuscular epinephrine/intravenous methylprednisolone injection and repeated salbutamol/ipratropium/budesonide inhalation. After 5 hours, extubation and spontaneous breathing were successful without wheezing. Next day, pulmonary function test showed moderate an obstructive airway disease pattern, and she was discharged with inhaled fluticasone/salmeterol, oral methylprednisolone, and montelukast. We can exclude anaphylaxis, because serum tryptase obtained at the Emergency Department was 0.0 mg/dL and the absence of skin lesions and angioedema at arrival. Baek-ok injection (glutathione) should be carefully performed in asthma patients.
Abstract
Baek-ok injection (glutathione) has been widely used antioxidant therapy to whiten and has antiaging effects in Korea. Glutathione is an enzyme which synthesizes leukotriene, then it can induce asthma attack theoretically; however, there have been few case reports concerning this therapy. In this report, we described a 41-year-old woman who developed glutathione-induced life-threatening asthma attack. She has asthma history controlled by an intermittent salbutamol inhaler. She developed general weakness and dyspnea right after glutathione injection, and injection was discontinued. Dyspnea was progressively aggravated, and she lost consciousness with shock. Cardiopulmonary resuscitation was started, and she arrived at the Emergency Department with wheezing, hypoxia, severe respiratory acidosis, and nonmeasurable blood pressure. Intubation and mechanical ventilation were started with intramuscular epinephrine/intravenous methylprednisolone injection and repeated salbutamol/ipratropium/budesonide inhalation. After 5 hours, extubation and spontaneous breathing were successful without wheezing. Next day, pulmonary function test showed moderate an obstructive airway disease pattern, and she was discharged with inhaled fluticasone/salmeterol, oral methylprednisolone, and montelukast. We can exclude anaphylaxis, because serum tryptase obtained at the Emergency Department was 0.0 mg/dL and the absence of skin lesions and angioedema at arrival. Baek-ok injection (glutathione) should be carefully performed in asthma patients.
참고문헌 (17)
- Dickinson DA, "Glutathione in defense and signaling : lessons from a small thiol", Ann N Y Acad Sci, 973, pp.488~504 (2002)
- Exner R, "Therapeutic potential of glutathione", Wien Klin Wochenschr, 112, pp.610~616 (2000)
- Sonthalia S, "Glutathione as a skin whitening agent : facts, myths, evidence and controversies", Indian J Dermatol Venereol Leprol, 82, pp.262~272 (2016)
- Weschawalit S, "Glutathione and its antiaging and antimelanogenic effects", Clin Cosmet Investig Dermatol, 10, pp.147~153 (2017)
- Wu G, "Glutathione metabolism and its implications for health", J Nutr, 134, pp.489~492 (2004)
- Narayanankutty A, "Biochemical pathogenesis of aspirin exacerbated respiratory disease(AERD)", Clin Biochem, 46, pp.566~578 (2013)
- Dobovišek A, "Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma : a theoretical study", J Pharmacokinet Pharmacodyn, 38, pp.261~278 (2011)
- Montuschi P, "Role of Leukotrienes and Leukotriene Modifiers in Asthma", Pharmaceuticals(Basel), 3, pp.1792~1811 (2010)
- Marrades RM, "Nebulized glutathione induces bronchoconstriction in patients with mild asthma", Am J Respir Crit Care Med, 156(2 Pt 1), pp.425~430 (1997)
- Buka RJ, "Anaphylaxis and clinical utility of real-world measurement of acute serum tryptase in UK Emergency Departments", J Allergy Clin Immunol Pract, 5, pp.1280~1287.e2 (2017)
- Simons FE, "World Allergy Organization Anaphylaxis Guidelines : 2013 update of the evidence base", Int Arch Allergy Immunol, 162, pp.193~204 (2013)
- Gokirmak M, "The role of oxidative stress in bronchoconstriction due to occupational sulfur dioxide exposure", Clin Chim Acta, 331, pp.119~126 (2003)
- Hajj AM, "Role of tachykinins in sulfur dioxide-induced bronchoconstriction in anesthetized guinea pigs", J Appl Physiol, 80, pp.2044~2050 (1996)
- Yoshimoto T, "Properties of highly purified leukotriene C4 synthase of guinea pig lung", J Clin Invest, 81, pp.866~871 (1988)
- Lewis RA, "Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases", N Engl J Med, 323, pp.645~655 (1990)
- Hagan JB, "Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma : a Systematic Review and Meta-Analysis", J Allergy Clin Immunol Pract, 5, pp.990~997.e1 (2017)
- Nami Shrestha Palikhe, "Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease", Yonsei Medical Journal, 50(6), pp.744~750 (2009), 연세대학교의과대학